A Study to Evaluate How the Study Drug Moves Through the Body, Adverse Events, and How the Body Tolerates ABBV-547 Injections
Clinical trial NCT07232004 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07232004
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-24
- Primary completion
- 2027-08-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.